Expedited Review Process

Prior to their participation in clinical trials, the CURC requires pharmaceutical sponsors or other interested parties to request an in depth Expedited Review of their protocols, drugs and projects. The CURC will sign a blanket confidentiality agreement on behalf of Consortium members, employees and associates as all relevant information stemming from the Expedited Review will be internally disseminated.

CURC Headquarters organizes the Expedited Review after a mutually agreeable date has been set and develops the agenda along with the Sponsor. The Consortium provides Presentation Guidelines to assist the Sponsor to structure their presentation and the content of the Review. As Sponsors present their drug trials, a CURC Review Team under the direction of the Head Reviewer prepares a draft Assessment Report which includes: project summary, comments, recommendations, budget details, and priority rating. Final Assessment Reports are forwarded to the Sponsor in approximately 15 business days of the presentation.

www.curc.ca © 2000-2008 Canadian Urology Research Consortium | revised 3-Dec-2004
website maintained by WCI | contact webmanager: webmanager [at] curc [dot] ca